We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Thrombozytenaggregationshemmer (Update 2023).
- Authors
Wascher, Thomas C.; Stulnig, Thomas M.; Saely, Christoph H.; Stechemesser, Lars
- Abstract
Summary: Acute thrombotic complications as a key feature of accelerated atherothrombotic disease typically precipitate cardiovascular events and therefore strongly contribute to cardiovascular morbidity and mortality in patients with diabetes. Inhibition of platelet aggregation can reduce the risk for acute atherothrombosis. The present article represents the recommendations of the Austrian Diabetes Association for the use of antiplatelet drugs in patients with diabetes according to current scientific evidence.
- Subjects
BLOOD platelets; DRUGS
- Publication
Wiener Klinische Wochenschrift, 2023, Vol 135, Issue 1, p161
- ISSN
0043-5325
- Publication type
Article
- DOI
10.1007/s00508-023-02168-6